Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
FLUCONAZOLE
Teva UK Limited
2 Mg/Ml
Solution for Infusion
2010-08-13
IRISH MEDICINES BOARD ACT 1995, AS AMENDED MEDICINAL PRODUCTS (CONTROL OF PLACING ON THE MARKET) REGULATIONS, 2007, AS AMENDED PA0237/064/001 Case No: 2087402 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to Transferred from PA0585/015/001. TEVA UK LIMITED BRAMPTON ROAD, HAMPDEN PARK, EASTBOURNE, EAST SUSSEX BN22 9AG, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations, in respect of the product FLUCONAZOLE 2 MG/ML SOLUTION FOR INFUSION the particulars of which are set out in the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 13/08/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 16/08/2010_ _CRN 2087402_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fluconazole 2mg/ml Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Fluconazole 2mg per ml. Each 25ml vial contains 50mg fluconazole. Each 50ml vial contains 100mg fluconazole. Each 100ml vial contains 200mg fluconazole. Also contains: sodium 3.8 mmol per 25ml vial, 7.6 mmol per 50 ml vial and 15.2 mmol per 100 ml vial. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for Infusion. Fluconazole 2mg/ml Solution for Infusion is a clear colourless solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Therapy may be started before the res Read the complete document